Fortrea

Activities: Research & Development

Trending Articles

  1. FUJIFILM Cellular Dynamics opens new iPSC manufacturing facility in US The new site will serve as the company's headquarters and will increase Fujifilm's capacity for induced pluripotent stem cell development and manufacturing, as demand increases...
  2. Ashland opens world-class pharmaceutical excipient production facility in Nanjing, China Ashland now manufactures its major brands of excipients in Nanjing to better serve China’s burgeoning pharmaceutical industry
  3. TrakCel and Lonza complete gene therapy manufacturing and orchestration solutions integration milestone TrakCel, supplier of cellular orchestration solutions for clinical trials and commercial therapies to the cell and gene therapy (CGT) industry, has completed a milestone in its...
  4. Gerresheimer and Portal Instruments team up to commercialise PRIME Nexus reusable autoinjector Gerresheimer and Portal Instruments are joining forces to develop and manufacture the PRIME Nexus syringe-based, reusable, connected autoinjector platform, offering...
  5. Halocarbon gets FDA approval to market Sevoflurane for human anesthetic market Halocarbon Products Corporation, a leading worldwide producer of specialty fluorochemicals, including fluorinated inhalation anesthetics, has received approval to market the...

Upcoming event

CPhI North America

2–4 June 2026 | Exhibition | Pennsylvania, US See all

Related Content

Distribution

Fortrea increases patient access capabilities and cold chain expertise

Fortrea’s non-commercial specialty pharmacy expansion delivers flexible, scalable solutions to customers and medications direct to patients
Finance

Fortrea completes expansion of clinical pharmacology solutions

Adds speed and agility with cGMP production at on-site pharmacies, adds capacity, improves flexible therapeutic capabilities and enhances experience for study volunteers
Subscribe now